Ongentys and Swelling - a phase IV clinical study of FDA data

Summary:

Swelling is reported as a side effect among people who take Ongentys (opicapone), especially for people who are male, 60+ old, also take Amantadine, and have Parkinson's disease.

The phase IV clinical study analyzes which people have Swelling when taking Ongentys. It is created by eHealthMe based on reports of 1,236 people who have side effects when taking Ongentys from the FDA, and is updated regularly.

What is Ongentys?

Ongentys has active ingredients of opicapone. eHealthMe is studying from 1,239 Ongentys users. Check the latest studies of Ongentys.

What is Swelling?

Swelling is found to be associated with 2,296 drugs and 2,893 conditions by eHealthMe. Check the latest studies of Swelling.



On Jul, 19, 2026

1,236 people reported to have side effects when taking Ongentys.
Among them, 13 people (1.05%) have Swelling.

Could Ongentys cause Swelling?

Among these 13 people:

What is the gender of people who have Swelling when taking Ongentys? *

  • female: 0.0 %
  • male: 100 %

What is the age of people who have Swelling when taking Ongentys? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

What are other drugs people take besides Ongentys? *

  1. Amantadine: 12 people, 92.31%
  2. Naproxen: 9 people, 69.23%
  3. Mirtazapine: 9 people, 69.23%
  4. Zopiclone: 8 people, 61.54%
  5. Tramadol: 3 people, 23.08%
  6. Acetaminophen: 3 people, 23.08%
  7. Ropinirole Hydrochloride: 2 people, 15.38%
  8. Synthroid: 1 person, 7.69%
  9. Sinemet: 1 person, 7.69%

What are other side effects people have besides Swelling? *

  1. Pain: 13 people, 100.00%
  2. Weight Decreased: 12 people, 92.31%
  3. Ligament Sprain (ligament stretched): 12 people, 92.31%
  4. Depressed Mood: 12 people, 92.31%
  5. Depression: 12 people, 92.31%
  6. Dyskinesia (abnormality or impairment of voluntary movement): 12 people, 92.31%
  7. Dyspnea (difficult or laboured breathing): 12 people, 92.31%
  8. Fall: 12 people, 92.31%
  9. Fatigue (feeling of tiredness): 12 people, 92.31%
  10. Freezing Phenomenon: 12 people, 92.31%

What are the existing conditions these people have? *

  1. Parkinson's Disease: 13 people, 100.00%
  2. Pain: 3 people, 23.08%

* Approximation only. Some reports may have incomplete information.

Do you take Ongentys and have Swelling?

- Check whether Swelling is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ongentys:

Swelling treatments and more:

How severe was Swelling and when was it recovered:

Expand to all the drugs that have ingredients of opicapone:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ongentys:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Swelling:

Browse all the conditions that are associated with Swelling:


How the study uses the data?

The study uses data from the FDA. It is based on opicapone (the active ingredients of Ongentys) and Ongentys (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: